RafaelFonsecaMD

PubMed

• Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma.
  Ghobrial, I., Gormley, N., Kumar, S., Mateos, M., Bergsagel, P., Chesi, M., Dhodapkar, M., Dispenzieri, A., Fonseca, R., Getz, G., Kastritis, E., Kristinsson, S., Mart...> ;Blood Cancer Discovery. 2024 Mar 4
• Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review.
  Fortuna, G., Dahal, R., Mohan, M., Mian, H., Mohyuddin, G., Neupane, K., Schmidt, T., Fonseca, R., Chakraborty, R., Koehn, K., Costa, L., Sborov, D.> ;Blood Cancer Journal. 2024 Jan 25
• Translocation t(14;16) in multiple myeloma: gangster or just part of the gang?
  Mian, H., Kaiser, M., Fonseca, R.> ;Blood Cancer Journal. 2024 Jan 16
• Measurable Residual Disease and Decision-Making in Multiple Myeloma.
  Derman, B., Fonseca, R.> ;Hematology/oncology Clinics of North America. 2024 Apr 1
• 1 citations
  Superior detection rate of plasma cell FISH using FACS-FISH.
  Gagnon, M., Midthun, S., Fangel, J., Schuh, C., Luoma, I., Pearce, K., Meyer, R., Ailawadhi, S., Arribas, M., Braggio, E., Fonseca, R., Rajkumar, S., Zepeda-Mendoza, C...> ;American Journal of Clinical Pathology. 2024 Jan 4
• 2 citations
  Impact of cytogenetic abnormalities on the risk of disease progression in solitary bone plasmacytomas.
  Udit Yadav, Shaji K Kumar, Linda B Baughn, Angela Dispenzieri, Patricia Greipp, Rhett Ketterling, Dragan Jevremovic, Francis K Buadi, David Dingli, Martha Q Lacy, Rafa...> ;Blood. 2023 Nov 30
• MRD negativity: considerations for older adults with multiple myeloma.
  Hira Mian, Tanya M Wildes, Christopher P Venner, Rafael Fonseca> ;Blood Cancer Journal. 2023 Nov 8
• Real-world Duration of Use and Dosing Frequency of Daratumumab in Patients With Multiple Myeloma in the United States.
  Rafael Fonseca, Eric E Chinaeke, Niodita Gupta-Werner, Alex Z Fu, Shuchita Kaila> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2023 Oct 1
• 1 citations
  Cancer-specific mortality in multiple myeloma: a population-based retrospective cohort study.
  Arleigh McCurdy, Hsien Seow, Gregory P Pond, Anastasia Gayowsky, Rajshekhar Chakraborty, Alissa Visram, Rayan Kaedbey, Anita D'Souza, Ghulam Rehman Mohyuddin, Tanya M ...> ;Haematologica. 2023 Dec 1
• 2 citations
  Response to COVID-19 Vaccination Post-CAR T Therapy in Patients With Non-Hodgkin Lymphoma and Multiple Myeloma.
  Wiedmeier-Nutor, J., Iqbal, M., Rosenthal, A., Bezerra, E., Garcia-Robledo, J., Bansal, R., Johnston, P., Hathcock, M., Larsen, J., Bergsagel, P., Wang, Y., Reeder, C....> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jun 1
• Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
  Rodrigo Fonseca, Mariano Arribas, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, ...> ;Blood Cancer Journal. 2023 May 26
• Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma.
  Muhamad Alhaj Moustafa, Ricardo Parrondo, Mays F Abdulazeez, Vivek Roy, Taimur Sher, Victoria R Alegria, Rahma M Warsame, Rafael Fonseca, Ahsan Rasheed, Wilson I Gonsa...> ;Anti-Cancer Drugs. 2024 Jan 1
• 7 citations
  Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
  Radhika Bansal, Mizba Baksh, Jeremy T Larsen, Matthew A Hathcock, David Dingli, A Keith Stewart, Prashant Kapoor, Taxiarchis Kourelis, Suzanne R Hayman, Rahma M Warsam...> ;Blood Cancer Journal. 2023 Apr 5
• 3 citations
  Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma.
  Rafael Fonseca, Thierry Facon, Mahmoud Hashim, Sandhya Nair, Jianming He, Eric Ammann, Annette Lam, Mark Wildgust, Shaji Kumar> ;The Oncologist. 2023 May 8
• 3 citations
  Impact of Disease Progression, Line of Therapy, and Response on Health-Related Quality of Life in Multiple Myeloma: A Systematic Literature Review.
  Rafael Fonseca, Diana Tran, Alyshia Laidlaw, Emily Rosta, Manvir Rai, Joana Duran, Eric M Ammann> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Jun 1
• 8 citations
  Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
  Rodrigo Fonseca, Mariano Arribas, Yael N Kusne, Miguel González Vélez, Heidi E Kosiorek, Richard Duke J Butterfield, Ilan R Kirsch, Joseph R Mikhael, A Keith Stewart, ...> ;Blood Cancer Journal. 2023 Mar 6
• 6 citations
  Impact of cytogenetic abnormalities on treatment outcomes in patients with amyloid light-chain amyloidosis: subanalyses from the ANDROMEDA study.
  Shaji Kumar, Angela Dispenzieri, Morie Gertz, Ashutosh Wechalekar, Giovanni Palladini, Raymond Comenzo, Rafael Fonseca, Arnaud Jaccard, Efstathios Kastritis, Stefan Sc...> ;Amyloid. 2023 Sep 1
• Almost a Centenarian-Bold, Forward, and Networking.
  Karl A Nath, Rafael Fonseca> ;Mayo Clinic Proceedings. 2023 Jan 1
• 15 citations
  Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;American Journal of Hematology. 2023 Jan 1
• 1 citations
  Therapy of childhood acute lymphoblastic leukemia in resource-poor geospaces.
  Moisés M Gallardo-Pérez, Robert Peter Gale, Oscar A Reyes-Cisneros, Daniela Sánchez-Bonilla, José A Fernández-Gutiérrez, Wendy Stock, Iván Murrieta-Álvarez, Juan Carlo...> ;Frontiers in Oncology. 2023 Jan 1
• Prognostic value of translocation 11;14 in patients with relapsed/refractory myeloma receiving anti-CD38 therapy.
  Ghulam Rehman Mohyuddin, Rajshekhar Chakraborty, Gregory S Calip, Mustafa S Ascha, Xiaoliang Wang, Samuel M Rubinstein, Sascha Tuchman, Luciano Costa, Benjamin Haaland...> ;Blood Cancer Journal. 2022 Dec 16
• Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
  Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood Cancer Journal. 2022 Nov 24
• Raise the Flag: Is Low QRS Voltage Ready to Advance to a Prognostic Factor?
  Olubadewa A Fatunde, Rafael Fonseca, Julie L Rosenthal> ;JACC. Cardiooncology. 2022 Nov 1
• 3 citations
  Assessing Patient-Reported Financial Hardship in Patients With Cancer in Routine Clinical Care.
  Sandeep S Voleti, Rahma Warsame, Carolyn Mead-Harvey, Sikander Ailawadhi, Atul Jain, Rafael Fonseca, Joan M Griffin, Nandita Khera> ;JCO Oncology Practice. 2022 Nov 1
• 2 citations
  Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood. 2022 Nov 3
• Join now to see all

Journal Articles

• Utilization of Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Myeloma: A Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consen...  
  John A Lust, Shaji K Kumar, Morie A Gertz, P Leif Bergsagel, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, Angela A Mayo, Wilson I Gonsalves, Rafael Fonseca, R..., Nature

Abstracts/Posters

• Myeloma Cells Addicted to Glutamine for Biomass Production Are Sensitive to Lenalidomide
  Rafael Fonseca, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Current Obstacles in Myeloma Management: Debating the Evidence 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Economic Burden of Disease Progression Among Transplant Eligible Multiple Myeloma Patients Who Have Received at Least One Line of Therapy in the US 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Addressing Current Questions and Controversies in the Management of Multiple Myeloma, Waldenstrom Macroglobulinemia, and Amyloidosis 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Debate: Value and Cost of Myeloma Therapy—We Can Afford It 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
• Join now to see all